{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:14:45Z","timestamp":1768407285526,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.7759\/cureus.66859","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:59:37Z","timestamp":1723643977000},"source":"Crossref","is-referenced-by-count":1,"title":["Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA)-Associated Vasculitis With Rare Clinical Manifestations After SARS-CoV-2 Multisystem Inflammatory Syndrome in a 14-Year-Old Boy"],"prefix":"10.7759","author":[{"given":"Vasiliki M","family":"Kymioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Karava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kakleas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-023-00853-4","article-title":"Childhood-onset ANCA-associated vasculitis: single center experience from central California","volume":"21","author":"Singh D","year":"2023","unstructured":"Singh D, Sukumaran S. Childhood-onset ANCA-associated vasculitis: single center experience from central California. Pediatr Rheumatol Online J. 2023, 21:66. 10.1186\/s12969-023-00853-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao Y","year":"2011","unstructured":"Cao Y, Schmitz JL, Yang J, et al.. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol. 2011, 22:1161-7. 10.1681\/ASN.2010101058","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr A","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004, 51:92-9. 10.1002\/art.20077","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching AR","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, et al.. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020, 6:71. 10.1038\/s41572-020-0204-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae170","article-title":"Dual MPO\/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review","author":"Bettacchioli E","year":"2024","unstructured":"Bettacchioli E, Foulquier JB, Chevet B, et al.. Dual MPO\/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review. Rheumatology (Oxford). 2024, 10.1093\/rheumatology\/keae170","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-033092","article-title":"Acute ANCA vasculitis and asymptomatic COVID-19","volume":"147","author":"Powell WT","year":"2021","unstructured":"Powell WT, Campbell JA, Ross F, Pe\u00f1a Jim\u00e9nez P, Rudzinski ER, Dickerson JA. Acute ANCA vasculitis and asymptomatic COVID-19. Pediatrics. 2021, 147:e2020033092. 10.1542\/peds.2020-033092","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.epsc.2021.102103","article-title":"Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager","volume":"75","author":"Wintler T","year":"2021","unstructured":"Wintler T, Zherebtsov M, Carmack S, Muntean R, Hill SJ. Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager. J Pediatr Surg Case Rep. 2021, 75:102103. 10.1016\/j.epsc.2021.102103","journal-title":"J Pediatr Surg Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152047","article-title":"COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis","volume":"55","author":"Batu ED","year":"2022","unstructured":"Batu ED, Sener S, Ozen S. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis. Semin Arthritis Rheum. 2022, 55:152047. 10.1016\/j.semarthrit.2022.152047","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev286","article-title":"Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort","volume":"55","author":"Schirmer JH","year":"2016","unstructured":"Schirmer JH, Wright MN, Vonthein R, et al.. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford). 2016, 55:71-9. 10.1093\/rheumatology\/kev286","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein LR","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, et al.. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020, 383:334-46. 10.1056\/NEJMoa2021680","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka J","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022, 28:911-23. 10.1038\/s41591-022-01810-6","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac106","article-title":"Reply to Cimolai: Post-COVID syndrome and autoimmunity","volume":"226","author":"Acosta-Ampudia Y","year":"2022","unstructured":"Acosta-Ampudia Y, Anaya JM. Reply to Cimolai: Post-COVID syndrome and autoimmunity. J Infect Dis. 2022, 226:753-4. 10.1093\/infdis\/jiac106","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su Y","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022, 185:881-895.e20. 10.1016\/j.cell.2022.01.014","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05273-0","article-title":"Dysregulated naive B cells and de novo autoreactivity in severe COVID-19","volume":"611","author":"Woodruff MC","year":"2022","unstructured":"Woodruff MC, Ramonell RP, Haddad NS, et al.. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19. Nature. 2022, 611:139-47. 10.1038\/s41586-022-05273-0","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi M","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, et al.. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020, 126:1456-74. 10.1161\/CIRCRESAHA.120.317015","journal-title":"Circ Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2023.0074","article-title":"Interaction between genetic susceptibility and COVID-19 pathogenesis in pediatric multisystem inflammatory disorders: the role of immune responses","volume":"37","author":"Chen LN","year":"2024","unstructured":"Chen LN, Shou ZX, Jin X. Interaction between genetic susceptibility and COVID-19 pathogenesis in pediatric multisystem inflammatory disorders: the role of immune responses. Viral Immunol. 2024, 37:1-11. 10.1089\/vim.2023.0074","journal-title":"Viral Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8615-21","article-title":"MPO-ANCA-positive microscopic polyangiitis following COVID-19 infection","volume":"61","author":"Kawashima S","year":"2022","unstructured":"Kawashima S, Kishimoto M, Hibino T, Lee H, Sato Y, Komagata Y, Kaname S. MPO-ANCA-positive microscopic polyangiitis following COVID-19 infection. Intern Med. 2022, 61:567-70. 10.2169\/internalmedicine.8615-21","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","article-title":"Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?","volume":"19","author":"Caso F","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, Scarpa R. Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?. Autoimmun Rev. 2020, 19:102524. 10.1016\/j.autrev.2020.102524","journal-title":"Autoimmun Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.582166","article-title":"COVID-19-A theory of autoimmunity against ACE-2 explained","volume":"12","author":"McMillan P","year":"2021","unstructured":"McMillan P, Dexhiemer T, Neubig RR, Uhal BD. COVID-19-A theory of autoimmunity against ACE-2 explained. Front Immunol. 2021, 12:582166. 10.3389\/fimmu.2021.582166","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos V","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018, 18:134-47. 10.1038\/nri.2017.105","journal-title":"Nat Rev Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde B","year":"2011","unstructured":"Wilde B, van Paassen P, Witzke O, Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 2011, 79:599-612. 10.1038\/ki.2010.472","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.06.012","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"186","author":"Gruber CN","year":"2023","unstructured":"Gruber CN, Patel RS, Trachtman R, et al.. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2023, 186:3325. 10.1016\/j.cell.2023.06.012","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAC492.933","article-title":"Multiparametric investigation of spike-protein specific T-cell cytokine expression profile in children with symptomatic COVID-19 or multisystem inflammatory syndrome","volume":"9","author":"Filippatos F","year":"2022","unstructured":"Filippatos F, Tzanoudaki M, Tatsi EB, Efthymiou V, Liatsis M, Syriopoulou V, Michos A. Multiparametric investigation of spike-protein specific T-cell cytokine expression profile in children with symptomatic COVID-19 or multisystem inflammatory syndrome. Open Forum Infect Dis. 2022, 9:ofac492.933. 10.1093\/OFID\/OFAC492.933","journal-title":"Open Forum Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli E","year":"2008","unstructured":"Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature. 2008, 453:1051-7. 10.1038\/nature07036","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales JM","year":"2020","unstructured":"Ruiz de Morales JM, Puig L, Daud\u00e9n E, et al.. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020, 19:102429. 10.1016\/j.autrev.2019.102429","journal-title":"Autoimmun Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06692-8","article-title":"Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study","volume":"42","author":"Tesch F","year":"2023","unstructured":"Tesch F, Ehm F, Vivirito A, et al.. Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study. Clin Rheumatol. 2023, 42:2919-20. 10.1007\/s10067-023-06692-8","journal-title":"Clin Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03049-5","article-title":"Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care","volume":"21","author":"Syed U","year":"2023","unstructured":"Syed U, Subramanian A, Wraith DC, et al.. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. BMC Med. 2023, 21:363. 10.1186\/s12916-023-03049-5","journal-title":"BMC Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A\u00a0retrospective cohort study","volume":"56","author":"Chang R","year":"2023","unstructured":"Chang R, Yen-Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID-19: A\u00a0retrospective cohort study. EClinicalMedicine. 2023, 56:101783. 10.1016\/j.eclinm.2022.101783","journal-title":"EClinicalMedicine"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-83. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24590","article-title":"Consensus treatment plans for severe pediatric antineutrophil cytoplasmic antibody-associated vasculitis","volume":"74","author":"Morishita KA","year":"2022","unstructured":"Morishita KA, Wagner-Weiner L, Yen EY, et al.. Consensus treatment plans for severe pediatric antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken). 2022, 74:1550-8. 10.1002\/acr.24590","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277165-myeloperoxidase-anti-neutrophil-cytoplasmic-antibody-mpo-anca-associated-vasculitis-with-rare-clinical-manifestations-after-sars-cov-2-multisystem-inflammatory-syndrome-in-a-14-year-old-boy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:59:40Z","timestamp":1723643980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277165-myeloperoxidase-anti-neutrophil-cytoplasmic-antibody-mpo-anca-associated-vasculitis-with-rare-clinical-manifestations-after-sars-cov-2-multisystem-inflammatory-syndrome-in-a-14-year-old-boy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.66859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}